Voyager Therapeutics (VYGR) Enterprise Value Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.06% |
| Dec 31, 2025 | 26.34% |
| Sep 30, 2025 | 39.50% |
| Jun 30, 2025 | 41.89% |
| Mar 31, 2025 | 40.93% |
| Dec 31, 2024 | -15.51% |
| Sep 30, 2024 | -36.54% |
| Jun 30, 2024 | -36.03% |
| Mar 31, 2024 | -46.19% |
| Dec 31, 2023 | -94.26% |
| Sep 30, 2023 | -92.15% |
| Jun 30, 2023 | -84.22% |
| Mar 31, 2023 | -63.82% |
| Dec 31, 2022 | 10.33% |
| Sep 30, 2022 | -8.34% |
| Jun 30, 2022 | -3.55% |
| Mar 31, 2022 | -3.30% |
| Dec 31, 2021 | 26.83% |
| Sep 30, 2021 | 39.26% |
| Jun 30, 2021 | 37.75% |
| Mar 31, 2021 | 35.64% |
| Dec 31, 2020 | 35.66% |
| Sep 30, 2020 | 34.93% |
| Jun 30, 2020 | 29.86% |
| Mar 31, 2020 | 30.01% |
| Dec 31, 2019 | -80.69% |
| Sep 30, 2019 | -71.16% |
| Jun 30, 2019 | -66.97% |
| Mar 31, 2019 | -64.30% |
| Dec 31, 2018 | 7.84% |
| Sep 30, 2018 | -43.01% |
| Jun 30, 2018 | -38.78% |
| Mar 31, 2018 | -38.39% |
| Dec 31, 2017 | 3.08% |
| Sep 30, 2017 | 34.30% |
| Jun 30, 2017 | 30.72% |
| Mar 31, 2017 | 22.71% |
| Dec 31, 2016 | 10.25% |
| Sep 30, 2016 | -77.53% |
| Jun 30, 2016 | -140.71% |
| Mar 31, 2016 | -75.23% |
| Dec 31, 2015 | -2,662.43% |
| Sep 30, 2015 | -1,600.96% |